Scarica l'app Stockscreener
7.05
1.44%
0.10
Pre-mercato:
7.08
0.03
+0.43%
Compass Pathways Plc Adr Borsa (CMPS) Ultime notizie
Propel Bio Management LLC Makes New $2.92 Million Investment in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
ARK Investment Management LLC Buys 471,897 Shares of Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
FY2030 Earnings Forecast for CMPS Issued By HC Wainwright - MarketBeat
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Benzinga
Compass Pathways raises $200M from warrant exercises - Investing.com
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Sahm
Compass Pathways (NASDAQ:CMPS) Stock Price Down 6.9%Here's Why - MarketBeat
Sonoco Products posts upbeat Q4 earnings, joins Compass Pathways, Masimo, Itron and other big stocks moving higher on Tuesday - MSN
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - Bitget
Magic Mushrooms, Hard Cash: Compass Pathways’ Trial Win, Fast Raise - MarketBeat
Cathie Wood’s ARK sells DraftKings stock, buys Figma and Compass Pathways - Investing.com South Africa
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates - Finviz
Compass Pathways prices $150 million public offering of ADSs By Investing.com - Investing.com South Africa
Compass Pathways prices $150 million public offering of ADSs - Investing.com
Compass Pathways announces $150 million ADS offering - Investing.com India
Compass Pathways (NASDAQ:CMPS) Shares Gap UpShould You Buy? - MarketBeat
Rezolve AI PLC (NASDAQ:RZLV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Mister Car Wash, Inc. (NYSE:MCW) Given Consensus Rating of “Hold” by Analysts - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Compass Pathways announces $150 million ADS offering By Investing.com - Investing.com UK
COMPASS Pathways touts Phase III psilocybin wins in TRD, eyes FDA NDA and expedited review - Yahoo Finance
Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday - Benzinga
Compass Pathways stock soars after positive Phase 3 trial results By Investing.com - Investing.com India
Compass Pathways stock soars after positive Phase 3 trial results - Investing.com
Compass Pathways reports positive phase 3 results for depression drug - Investing.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - Defense World
Compass Pathways to release new clinical data on psilocybin trials - Investing.com India
Compass Pathways to release new clinical data on psilocybin trials By Investing.com - Investing.com South Africa
What is Lifesci Capital’s Estimate for CMPS FY2025 Earnings? - Defense World
COMPASS Pathways Plc ADR (CMPS) Price Forecast: Bullish Reversal Gains Structure - FXEmpire
COMPASS Pathways plc's (NASDAQ:CMPS) institutional investors lost 16% over the past week but have profited from longer-term gains - Sahm
COMPASS Pathways (NASDAQ:CMPS) Stock Price Down 7.6%Should You Sell? - MarketBeat
Green Plains, Inc. (NASDAQ:GPRE) Given Average Rating of “Hold” by Analysts - Defense World
Nuclear Stocks To Watch Today – January 22nd - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Expand Energy Corporation (NASDAQ:EXE) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Investors Buy Large Volume of COMPASS Pathways Call Options (NASDAQ:CMPS) - Defense World
COMPASS Pathways Target of Unusually High Options Trading (NASDAQ:CMPS) - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading Down 5.5%What's Next? - MarketBeat
Commonwealth Equity Services LLC Boosts Position in Fidelity Enhanced Emerging Markets ETF $FEMR - Defense World
CMPS: COMP360 is poised to transform TRD and PTSD care with rapid, durable efficacy and broad support - TradingView — Track All Markets
CMPS: COMP360 is set to transform psychiatric care for PTSD and TRD with rapid, durable outcomes - TradingView — Track All Markets
COMPASS Pathways (NASDAQ:CMPS) Sets New 1-Year HighShould You Buy? - MarketBeat
CMPS: COMP360 demonstrates rapid, durable efficacy in TRD and PTSD, supporting near-term commercialization - TradingView — Track All Markets
Compass Pathways stock rises after FDA accepts IND for PTSD treatment By Investing.com - Investing.com South Africa
Compass Pathways stock rises after FDA accepts IND for PTSD treatment - Investing.com
Compass Pathways (Nasdaq:CMPS) Enters Strategic Collaboration with Radial Health - Kalkine Media
Compass Pathways forms seventh strategic collaboration with Radial Health By Investing.com - Investing.com India
Compass Pathways forms seventh strategic collaboration with Radial Health - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Simplify Asset Management Inc. Purchases Shares of 290,000 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Why COMPASS Pathways plc (CMPS) Draws Both Optimism and Caution - Finviz
1.54%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):